No Time to Die passes F9 in global box office

No Time to Die passed F9: The Fast Saga in global box office.

The 25th James Bond film’s worldwide box office was $734.1 million as of early Sunday afternoon, according to Box Office Mojo.

That put No Time to Die at the top spot for 2021 among movies released by major U.S. studios. F9 previously held that spot at $721.1 million.

Since late last week, various outlets, such as digital service Puck, Deadline: Hollywood, and Forbes.com said No Time to Die was on the verge of passing F9.

In the U.S., No Time to Die, in its seventh weekend, was No. 7 with $2.7 million. The movie has been available via premium video on demand since Nov. 9. The U.S. theatrical total is $154.7 million, or about 21 percent of the global total.

NTTD to be 2021’s box office champ, Puck says

No Time to Die poster

No Time to Die will end up 2021’s box office champion ” with a big asterisk” among major studio films, the digital Puck news service said in an analysis.

No Time to Die is now projected to cross F9’s $721.1 million global number sometime around Thanksgiving, according to both MGM, its domestic distributor, and Universal, which handled most overseas territories,” wrote Puck’s Matthew Belloni, a former editor of The Hollywood Reporter and a one-time entertainment lawyer.

“With neither Eternals nor Venom: There Will Be Carnage getting a China release, and nothing major coming before year’s end (except Spider-man: No Way Home, which drops Dec. 17 and will earn mostly in 2022), it’s safe to say the Bond film played a long game and came out on top.”

The asterisk cited by Belloni is how the COVID-19 pandemic shrunk the movie-going audience in 2021. In 2019, Avengers: Endgame generated almost $2.8 billion at the global box office. That is “between three and four times the likely Bond number,” Belloni wrote.

The No Time to Die global box office, he added, is “still notable, given the geezer-skewing audience for the franchise. Studio research showed that 25 percent of the over-35 audience said this was their first movie back in theaters, I’m told.”

No Time to Die debuted in the U.K. in late September and in the U.S. in early October. Australia saw the film released on Nov. 11.

The Box Office Mojo website listed the Bond movie’s global box office at $709.2 million as of Thursday morning.

Two films released in Asia, The Battle at Lake Changjin and Hi, Mom, each have box office totals above $800 million.

No Time to Die passes $150M in U.S., $700M globally

No Time to Die is forecast to become the sixth movie to pass the $150 million mark in the U.S. this year according to Exhibitor Relations Co., which tracks box office data.

At the same time, the film passed $700 million worldwide, The Wrap reported. The entertainment news site listed the figure as $708 million. No Time to Die opened in Australia on Nov. 11, one of the last major markets for the Bond movie. No Time to Die is close to catching F9: The Fast Saga’s $721 million.

In the U.S. the 25th James Bond film is estimated to generate $4.6 million for the Nov. 12-14 weekend. That’s down just 23 percent from last weekend. The movie has been available on video on demand (VOD) since Nov. 9. The rental price is $19.99 for 48 hours.

Only two 2021 movies, Shang-Chi and the Legend of the Ten Rings and Venom: Let There Be Carnage, have surpassed the $200 million mark in the U.S.

The COVID-19 pandemic has, in effect, reduced the size of the U.S. movie-going market. In pre-pandemic times, 2012’s Skyfall generated U.S. box office of $304.4 million while 2015’s SPECTRE had $200.1 million.

COVID-19 also has held down the global box office. In 2019, Avengers: Endgame had a worldwide box office of almost $2.8 billion. No movie has reached $1 billion in 2021.

No Time to Die passes $600M in global box office

No Time to Die logo

No Time to Die has passed the $600 million global box office mark as the 25th James Bond movie nears the end of its worldwide rollout.

The movie’s global figure is now an estimated $605.8 million, according to Box Office Mojo. This weekend saw the Bond film debut in China.

In the U.S., No Time to Die’s fourth weekend was an estimated $7.8 million for Oct. 29-31. That was 36 percent below the Oct. 22-24 weekend. A decline weekend decline below 50 percent is considered a strong box office performance.

In the U.S., No Time has generated an estimated box office of $133.3 million. That’s not as popular as globally but nothing to sneeze at.

Context: Globally, No Time to Die is one of the most popular films of the COVID-19 pandemic era. The champ is F9: The Fast Saga at $721.1 million.

However, the pandemic has changed things. The champ for 2019 (the last year before the pandemic) was Avengers: Endgame at almost $2.8 billion.

Keep in mind: These figures are called grosses (as opposed to profits) for a reason. The studios split the money with theaters.

No Time to Die’s production budget approached $300 million. Metro-Goldwyn-Mayer spent millions of dollars beyond that in marketing.

Conclusion: It’s good news and bad news. Bond still is popular overall. It’s not so great for those who pay the bills. All concerned might want to be more budget-conscious for Bond 26.

NTTD passes $500 million global mark

No Time to Die surpassed the $500 million global box office mark this weekend. (UPDATE: The worldwide figure is at an estimated $525.7 million, according to Box Office Mojo.)

Before the COVID-19 pandemic, that would have been cause for mourning after four weeks in theaters worldwide and three weekends in the U.S. Before COVID-19, Bond would have been a candidate for a billion-dollar global box office.

However, in a post-pandemic marketplace, the 25th James Bond film, already ranks as one of the most popular movies in terms of movie theater box office.

No Time to Die passing the $500 million mark was noted in a story by TheWrap.

The highest COVID era box office currently is F9: The Fast Saga at $716.6 million. No Time to Die has yet to be released in China, Australia and New Zealand.

No Time to Die completed principal photography in the fall of 2019, before COVID-19 began to spread across the world. It has been delayed three times because of the pandemic. ‘

Meanwhile, estimates of No Time to Die’s third weekend in the U.S. were released. The Bond film came in No. 3 behind Dune, the major new movie out this weekend, and Halloween Kills. Here’s a tweet from Exhibitor Relations Co.

If No Time to Die passes F9 globally , that will be a sign that James Bond remains very popular. At the same time, a movie can be popular while unprofitable at least during its theatrical release.

No Time to Die had a production cost approaching $300 million. There were additional advertising and marketing expenditures. What’s more, the studios involved (Metro-Goldwyn-Mayer and Universal) only get about half of the box office. In China, it’s only 25 percent.

As ever, we will see.

UPDATE: The U.S. weekend box office estimate is $11.9 million. The final figure will be out on Oct. 25.

No Time to Die to get China release, Variety says

No Time to Die will be released in China, Variety reported, citing official local media.

Getting a release in the world’s most populous nation will provide an opportunity to boost the movie’s global box office. Studios only keep 25 percent of the box office take in China. But the country is such a huge market, it’s considered a plus.

No specific date has been determined for the movie’s release in China, Variety said.

The 25th James Bond film is the most expensive in the series produced by Eon Productions. No Time to Die’s production costs approached $290 million as of mid-2020, according to a U.K. regulatory filing.

The COVID-19 pandemic has caused the movie to be delayed three times. It’s now set to come out in the U.K. and other countries late this month and on Oct. 8 in the United States.

The pandemic has held down movie attendance generally.

The highest global box office so far this year was generated by F9: The Fast Saga, with almost $711 million. In pre-pandemic 2019, the No. 1 global box office was Avengers: Endgame at almost $2.8 billion.

No Time to Die will be released in theaters exclusively. Recent marketing efforts, including a new U.S. ad that debuted Sept. 9, have emphasized that aspect heavily.

Bond 25 questions: The marketing & box office edition

No Time to Die logo

We’re a month away from No Time to Die being released in the U.K. It appears the 25th James Bond film is done with delays and ready to confront the COVID-19 pandemic head on. Naturally, the blog has questions.

What’s the movie’s global box office going to be?

In the pandemic era, the movie with the largest global box office total is F9: The Fast Saga at about $704 million. Can No Time to Die match or exceed that? Naturally, Bond fans think so. But box office totals depend on more than hard-core fans.

What are the marketing dynamics?

To begin with, it’s a three-headed monster.

–You have Eon Productions, which makes the movies. Eon’s Michael G. Wilson said in 2015 that the company really manages the marketing. The distributors just execute Eon’s plan.

“We create it, they execute it,” Wilson said at that time.

–You have Metro-Goldwyn-Mayer, Bond’s home studio, which foots the bills. No Time to Die is being distributed in North America by United Artists Releasing, a joint venture of MGM and Annapurna Pictures.

–You have Universal, which is distributing the film internationally. Supposedly, Universal was selected because of its track record, which included turning The Fast and the Furious series into a $1 billion per film juggernaut per film prior to COVID-19. In that case, Universal ran the whole show. Now it’s dealing with another studio and a strong-willed production company.

On Aug. 24, Vulture, the arts website of New York magazine, had a story about the difficulty in scheduling movies amid COVID-19. It quoted someone it identified only as ” a person with knowledge of business practices at Eon.

“They’ve lost so much money by moving [No Time to Die]; the marketing has gotten stale,” this person says. “The Broccolis care more about the U.K. than anything — making it a big hit in the U.K., a decent hit in the U.S. and the rest of the world.” (emphasis added)

If true, it’d be interesting to know what MGM/United Artists Releasing thinks about that. It’d also be interesting to get the view of Universal, responsible for a lot more than just the U.K.

Anything to be on the lookout for?

The marketing is gearing up. Some commercials have run recently. Assuming there isn’t another delay (there have been five to date), we’ll be getting to judge the marketing efforts for ourselves.